Navigation Links
Sciton Introduces ProFractional-XC(TM), High-Speed, Dual-Mode Fractional Laser
Date:5/21/2008

PALO ALTO, Calif., May 21 /PRNewswire/ -- Sciton Inc., a manufacturer of laser and light-based skin sculpting and less-invasive aesthetic solutions, has announced the introduction of an additional fractional device, the ProFractional-XC. The ProFractional-XC offers two new features -- significantly higher speed, and user-controlled, variable-depth thermal coagulation -- in addition to great patient results and excellent practice economics.

Up to four times faster than competitive instruments, ProFractional-XC allows greater patient throughput, which eventually leads to significant revenue increase for aesthetic practices. An early user of the ProFractional-XC, Dr. Michael Kaminer, a Board Certified Dermatologist in Chestnut Hill, Massachusetts, states, "ProFractional-XC is very fast and easy to use, which makes it a procedure that physicians can easily fit into their busy schedules. The results are fantastic, and the versatility of the device is quite impressive." There are no consumables or disposable tips used by ProFractional-XC, and unlimited pulses are available during the warranty period, resulting in excellent economic profile and no cost-per-use revenue impact.

Like the original ProFractional(TM), released by Sciton in early 2007, the ProFractional-XC allows physicians to match the desired result with the desired amount of downtime through control of the depth and density of the treatment. For the first time ProFractional-XC technology allows the independent selection of ablation and thermal coagulation. With ProFractional-XC physicians can precisely control thermal injury and post-treatment inflammation, something not possible with early fractional devices. With other technologies, the degree of thermal damage cannot be adjusted and is dependent only upon the type of laser chosen.

Dr. Jason Pozner, a Board Certified Plastic Surgeon in Boca Raton, Florida comments, "ProFractional-XC gives the physician the option to use or not to
'/>"/>

SOURCE Sciton Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Anthem Blue Cross and Blue Shield Introduces Transparency Initiative in Maine
2. Anthem Blue Cross Introduces Industrys Most Comprehensive Transparency Initiative to California
3. Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads
4. Draeger Introduces the AirBoss Series Self-Contained Breathing Apparatus Approved to: NFPA 1981, 2007 Standards
5. Metametrix Introduces the New Neopterin/Biopterin Profile
6. Ortho Organizers(R) Introduces New Premium Product Line - O2 Select(TM) Orthodontic Instruments
7. Integrium Introduces Its Integrium Clinical Excellence (ICE) Methodology to Assure Consistent Delivery of Sponsor Clinical Trials
8. Anthem Blue Cross and Blue Shield in Connecticut Introduces Industrys First Electronic Tool to Help Members Search In-Network Doctors and Hospitals; Transparency Tool to Enable Searches Via Web-Enabled Cell Phones or Hand-Held Devices
9. Netsmart Technologies Introduces the Netsmart Connect(TM) Suite of Solutions for Behavioral and Public Healthcare
10. Anthem Blue Cross and Blue Shield Introduces Industrys Most Comprehensive Transparency Initiative to Wisconsin
11. Beautiful Teeth Not Just for the Dentists Office Anymore / SpaBrite Teeth Whitening System(TM) Introduces Innovative, New Teeth Whitening Experience To Spas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...mmunications announces a highly effective and unco...ruggling to make an economic recovery. , ...ears is the type of challenge that could send aili...to Dr. David Benton, business growth expert and au...– The Rfactor Intensive . “Fear is ...
(Date:11/25/2009)...swire/--TheBartleHallConventionCenterwilltemporari...whenKansasCityhoststhelatestinaseriesofmassivefree...enthasthepotentialtobethebiggestoneyet,becauseitwi...daysinsteadofoveraweekend,"SheriWood,executivedire...heNationalAssociationofFreeClinics(NAFC). ,, At...
(Date:11/25/2009)...SentinelleMedicalInc.,aleadingmanufacturerofbreast...uiteofnewleadingedgeclinicalapplicationsonitsAegis...ologicalSocietyofNorthAmerica(RSNA)annualmeetingin...icationsleveragetheuniquehighqualityimagesgenerate...tmultipleimagingmodalitiesformulti-parametricasses...
(Date:11/25/2009)...e-USNewswire/--TheBlackAIDSInstituterecentlyheldBo...ipfor2010. ,, ThenewBoardMembersareahighlydiver...finance,governmenthealthprograms,editorial,andbusi...geofpersonalbackgroundsincludingbothheterosexualan...ndrepresentingmultipleagegroups. ,, (Photo: htt...
(Date:11/25/2009)... cancer who were treated with cisplatin-based chem...eurological side effects and Raynaud-like phenomen..., according to a new study published online Novemb...tute . , Marianne Brydy, M.D., of the Department...rgen, Norway, and colleagues conducted a cross-sec...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...ason is the busiest shopping time of the year. In ...s on Black Friday weekend this year according to a...ually during this time, economists pay close atten...nality Continuum and Consumer Behavior, has taken ...
...Medical research has revealed much about cancer pr...icans, and are they acting on it" Today, at the A...ual International Conference on Frontiers in Cance... prevention science into public health policy. , ...
...r Relations Program Sets Stage for Increased Visib...vestors, CEDAR KNOLLS, N.J., Dec. 6 Emisphere,Te...that it has retained Adam,Friedman Associates, LLC...apeutic molecules and pharmaceutical,compounds usi...
...ation Focuses on Discovery of Small-Molecule Drugs...y, SOUTH PLAINFIELD, N.J., Dec. 6 PTC Therapeuti...d on the discovery, development,and commercializat...ular Atrophy (SMA) Foundation.,The collaboration b...
...6 - Atlantic Information,Services, Inc. (AIS) -- A...th Plan Week, Drug Benefit News and Specialty Phar...ts: Pharmacy Benefit Trends & Data. For the,past e...try. Trends revealed by this survey include the gr...
...uggest they might prevent cardiac arrest , ...s say they,re moving closer to using transplanted ...ring sudden cardiac arrest. , Working with mice, ...d study co-author Dr. Michael Kotlikoff, a profess...
Other Medicine News:Health News:Public health and cancer prevention: Success and future challenges in cancer policy 2Health News:Public health and cancer prevention: Success and future challenges in cancer policy 3Health News:Public health and cancer prevention: Success and future challenges in cancer policy 4Health News:Public health and cancer prevention: Success and future challenges in cancer policy 5Health News:Public health and cancer prevention: Success and future challenges in cancer policy 6Health News:Public health and cancer prevention: Success and future challenges in cancer policy 7Health News:Emisphere Names Adam Friedman Associates IR Agency of Record 2Health News:Emisphere Names Adam Friedman Associates IR Agency of Record 3Health News:PTC Therapeutics Announces Additional $1.6 Million Grant from the Spinal Muscular Atrophy Foundation 2Health News:PTC Therapeutics Announces Additional $1.6 Million Grant from the Spinal Muscular Atrophy Foundation 3Health News:2000-2007 Pharmacy Benefit Survey Results Just Released 2Health News:Cell Transplants Hold Promise for Heart Attack Survivors 2
(Date:11/25/2009)...PRNewswire/--PraxisElectronicMedicalRecordsreceive...sicians,(AAFP)FamilyPracticeManagement(FPM)2009EHR...ealthmaintenance,anddiseasemanagement,allcriticalf...ngdoctorsindicatingtheirEMRhadapositiveeffectindet...oneinthecountryinprovidingexcellenttrainingandsupp...
(Date:11/25/2009)...swire-FirstCall/--ERT(Nasdaq: ERES ),announcedtoda...CEO,andKeithSchneck,theCompany,sExecutiveVicePresi...erJaffrayHealthCareConferenceat1:30PMESTonDecember...esmayaccessthepresentationbyvisitingtheCompany,sco...alsobeaccessedat http://www.corporate-ir.net/ireye...
(Date:11/25/2009)...Newswire-USNewswire/--RemediumTechnologiesInc.,aco...rebleeding,wonfirstprizeand$10,000intheMostPromisi...2009,companyofficialsannouncetoday. ,, Selected...steampitchedtheirinventionattheGSCSecuritySummitco...edium( www.remediumtechnologies.com )isdevelopinga...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3More Than 5 000 Expected for Greater Chicago Food Depositorys 24th Annual Hunger Walk on Saturday June 20 at Montrose Harbor 49468 1More Than 5 000 Expected for Greater Chicago Food Depositorys 24th Annual Hunger Walk on Saturday June 20 at Montrose Harbor 49468 2American Dental Hygienists Association and Johnson 26 Johnson Healthcare Products Division of McNEIL PPC Inc Announce Honorees of HYGIENIST HERO 28 49463 1American Dental Hygienists Association and Johnson 26 Johnson Healthcare Products Division of McNEIL PPC Inc Announce Honorees of HYGIENIST HERO 28 49463 2American Dental Hygienists Association and Johnson 26 Johnson Healthcare Products Division of McNEIL PPC Inc Announce Honorees of HYGIENIST HERO 28 49463 3Lytix Biopharma and KAEL GemVax Announce Joint Clinical Trial to Combine LTX 315 and GV1001 Cancer Immunotherapy 12707 1Lytix Biopharma and KAEL GemVax Announce Joint Clinical Trial to Combine LTX 315 and GV1001 Cancer Immunotherapy 12707 2
...ed in study examining potential new ,GI-f... - Clinical results expected in second half o...rapeutics, Inc.,a privately held biopharmaceutical...lment in its two phase 3 trials HZ-CA-301 and HZ-C...nvestigational prescription NSAID,(non-steroidal a...
...acyclics,Inc. (Nasdaq: PCYC ) today announced pub...l highly-selective histone deacetylase (HDAC) inhi...ylase 8 (HDAC8)-specific inhibitor,PCI-34051 induc...February 7,issue of Leukemia., Histone deacetylas...naging a multitude of cellular functions. HDAC inh...
Other Medicine Technology:Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501 2Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501 3Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor 2Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor 3
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: